Common Contracts

INTEGRA LIFESCIENCES HOLDINGS CORPORATION COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT May 9, 2018

Underwriting Agreement • May 14th, 2018 • Integra Lifesciences Holdings Corp • Laboratory analytical instruments • New York

• Contract Type
  Underwriting Agreement
• Filed
  May 14th, 2018
• Company
  Integra Lifesciences Holdings Corp
• Industry
  Laboratory analytical instruments
• Jurisdiction
  New York

The undersigned understands that J.P. Morgan Securities LLC (“J.P. Morgan”) and Wells Fargo Securities, LLC (“Wells Fargo”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Integra LifeSciences Holdings Corporation, a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including J.P. Morgan and Wells Fargo, of shares of the common stock, par value $0.01 per share, of the Company (the “Common Stock”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.

INTEGRA LIFESCIENCES HOLDINGS CORPORATION COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT August 4, 2015

Underwriting Agreement • August 10th, 2015 • Integra Lifesciences Holdings Corp • Laboratory analytical instruments • New York

• Contract Type
  Underwriting Agreement
• Filed
  August 10th, 2015
• Company
  Integra Lifesciences Holdings Corp
• Industry
  Laboratory analytical instruments
• Jurisdiction
  New York

INTEGRA LIFESCIENCES HOLDINGS CORPORATION COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT November 6, 2013

Underwriting Agreement • November 13th, 2013 • Integra Lifesciences Holdings Corp • Laboratory analytical instruments • New York

• Contract Type
  Underwriting Agreement
• Filed
  November 13th, 2013
• Company
  Integra Lifesciences Holdings Corp
• Industry
  Laboratory analytical instruments
• Jurisdiction
  New York

The undersigned understands that Morgan Stanley & Co. LLC (“Morgan Stanley”), Merrill Lynch, Pierce, Fenner & Smith Incorporated (“Merrill Lynch”) and Wells Fargo Securities, LLC (“Wells Fargo”) propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with Integra LifeSciences Holdings Corporation, a Delaware corporation (the “Company”), providing for the public offering (the “Public Offering”) by the several Underwriters, including Morgan Stanley and Merrill Lynch, of shares of the common stock, par value $0.01 per share, of the Company (the “Common Stock”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Underwriting Agreement.